U.S., Sept. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07829406) titled 'A Study to See How Safe a New Medicine (NNC0642-1895) is in Healthy People' on Sept. 14.
Brief Summary: This study is testing a new medicine, in healthy adults to assess its safety and understand how it behaves in the body. The purpose of this study is to evaluate the safety, tolerability, and how the body responds to a single dose of NNC0642-1895 in healthy adults. Participant will either get study medicine (NNC0642-1895) or placebo (a treatment that has no active medicine in it). Which treatment a participant receives is decided by chance. NNC0642-1895 is a new medicine that is being tested in humans for the first time and is not...